Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review Article
  • Published:

Pharmacist’s role in hypertension management: a review of key randomized controlled trials

Journal of Human Hypertension volume 34, pages 487–494 (2020)Cite this article

Subjects

Abstract

Hypertension (HTN) is a leading cause of death and disability throughout the world. Yet, despite widely available treatment options, blood pressure (BP) control rates have remained relatively stagnant. One approach to address this issue is through collaborative care models, particularly those employing pharmacists. Numerous randomized controlled trials (RCT) have demonstrated the effectiveness of pharmacist interventions to improve BP control across primary care, community-based, and telemedicine models. A meta-analysis of 39 RCTs has demonstrated that pharmacist interventions significantly reduce both systolic and diastolic BP compared with controls across diverse patient populations. Pharmacists can contribute to HTN management in a variety of ways, including assisting with out-of-office monitoring, providing education, identifying and resolving nonadherence, and titrating antihypertensive therapy to achieve BP control. In this review, we discuss key trials conducted in recent years that support the role of pharmacists in HTN management and provide guidance on practical considerations for working collaboratively with pharmacists to improve BP control.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365:217–23.

  2. Woolf SH, Schoomaker H. Life expectancy and mortality rates in the United States, 1959-2017. JAMA. 2019;322:1996–2016.

    Article  Google Scholar 

  3. Muntner P, Carey RM, Gidding S, Jones DW, Taler SJ, Wright JT, et al. Potential U.S. population impact of the 2017 ACC/AHA high blood pressure guideline. J Am Coll Cardiol. 2018;71:109–18.

    Article  Google Scholar 

  4. Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Dennison Himmelfarb C, et al. ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults. JACC 2018;71:e127–248.

    Article  Google Scholar 

  5. Mills KT, Obst KM, Shen W, Molina S, Zhang HJ, He H, et al. Comparative effectiveness of implementation strategies for blood pressure control in hypertensive patients: a systematic review and meta-analysis. Ann Intern Med. 2018;168:110–20.

    Article  Google Scholar 

  6. Greer N, Bolduc J, Geurkink E, Rector T, Olson K, Koeller E, et al. Pharmacist-led chronic disease management: a systematic review of effectiveness and harms compared with usual care. Ann Intern Med. 2016;165:30–40.

    Article  Google Scholar 

  7. Santschi V, Chiolero A, Colosimo AL, Platt RW, Taffé P, Burnier M, et al. Improving blood pressure control through pharmacist interventions: a meta-analysis of randomized controlled trials. J Am Heart Assoc. 2014;3:e000718.

    Article  Google Scholar 

  8. Rui P, Okeyode T. National Ambulatory Medical Care Survey: 2016 National Summary Tables; 2016. https://www.cdc.gov/nchs/data/ahcd/namcs_summary/2016_namcs_web_tables.pdf.

  9. Association of American Medical Colleges. The 2019 update: the complexities of physician supply and demand: projections from 2017 to 2032; 2019. https://www.aamc.org/data-reports/workforce/data/2019-update-complexities-physician-supply-and-demand-projections-2017-2032.

  10. Carter BL, Coffey CS, Ardery G, Uribe L, Ecklund D, James P, et al. Cluster-randomized trial of a physician/pharmacist collaborative model to improve blood pressure control. Circ Cardiovasc Qual Outcomes. 2015;8:235–43.

    Article  Google Scholar 

  11. Drug Store News. Rx impact: a drug store news special report; 2016. p. 23. https://www.nacds.org/pdfs/DSN_RxIMPACT2016.pdf.

  12. Cheema E, Sutcliffe P, Singer DRJ. The impact of interventions by pharmacists in community pharmacies on control of hypertension: a systematic review and meta-analysis of randomized controlled trials. Br J Clin Pharmacol. 2014;78:1238–47.

    Article  CAS  Google Scholar 

  13. Tsuyuki RT, Al Hamarneh YN, Jones CA, Hemmelgarn BR. The effectiveness of pharmacist interventions on cardiovascular risk: the multicenter randomized controlled RxEACH trial. J Am Coll Cardiol. 2016;67:2846–54.

    Article  Google Scholar 

  14. Parker LJ, Hunte H, Ohmit A, Thorpe RJJ. Factors associated with black men’s preference for health information. Health Promot Pract. 2017;18:119–26.

    Article  Google Scholar 

  15. Victor RG, Ravenell JE, Freeman A, Leonard D, Bhat DG, Shafiq M, et al. Effectiveness of a barber-based intervention for improving hypertension control in black men: the BARBER-1 study: a cluster randomized trial. Arch Intern Med. 2011;171:342–50.

    Article  Google Scholar 

  16. Victor RG, Lynch K, Li N, Blyler C, Muhammad E, Handler J, et al. A cluster-randomized trial of blood-pressure reduction in black barbershops. N Engl J Med. 2018;378:1291–301.

    Article  Google Scholar 

  17. Victor RG, Blyler CA, Li N, Lynch K, Moy NB, Rashid M, et al. Sustainability of blood pressure reduction in black barbershops. Circulation. 2019;139:10–9.

  18. Poulson LK, Nissen L, Coombes I. Pharmaceutical review using telemedicine-a before and after feasibility study. J Telemed Telecare. 2010;16:95–9.

    Article  Google Scholar 

  19. Margolis KL, Asche SE, Bergdall AR, Dehmer SP, Groen SE, Kadrmas HM, et al. Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control a cluster randomized clinical trial. JAMA. 2013;310:46–56.

    Article  CAS  Google Scholar 

  20. Ashmann J, Rui P, Schappert S. Age differences in visits to office-based physicians by adults with hypertension: United States, 2013. NCHS Data Brief. 2016;263:1–7.

  21. Littauer SL, Dixon DL, Sisson EM, Salgado TM. Pharmacists providing care in the outpatient setting through telemedicine models: a narrative review. Pharm Pract. 2017;15:1–8.

    Google Scholar 

  22. Green BB, Cook AJ, Ralston JD, Fishman PA, Catz SL, Carlson J, et al. Effectiveness of home blood pressure monitoring, Web communication, and pharmacist care on hypertension control: a randomized controlled trial. JAMA. 2008;299:2857–67.

    Article  CAS  Google Scholar 

  23. Bodenheimer T, Lorig K, Holman H, Grumbach K. Patient self-management of chronic disease in primary care. JAMA. 2002;288:2469–75.

    Article  Google Scholar 

  24. Dehmer SP, Maciosek MV, Trower NK, Asche SE, Bergdall AR, Nyboer RA, et al. Economic evaluation of the home blood pressure telemonitoring and pharmacist case management to control hypertension (Hyperlink) trial. J Am Coll Clin Pharm. 2018;1:21–30.

    Article  Google Scholar 

  25. Margolis KL, Asche SE, Dehmer SP, Bergdall AR, Green BB, Sperl-Hillen JM, et al. Long-term outcomes of the effects of home blood pressure telemonitoring and pharmacist management on blood pressure among adults with uncontrolled hypertension: follow-up of a cluster randomized clinical trial. JAMA Netw Open. 2018;1:e181617.

    Article  Google Scholar 

  26. Margolis KL, Crain AL, Bergdall AR, Beran M, Anderson JP, Solberg LI, et al. Design of a pragmatic cluster-randomized trial comparing telehealth care and best practice clinic-based care for uncontrolled high blood pressure. Contemp Clin Trials. 2020:105939. https://doi.org/10.1016/j.cct.2020.105939 (in press).

  27. Centers for Disease Control and Prevention. Using the pharmacists’ patient care process to manage high blood pressure: a resource guide for pharmacists acknowledgments. Atlanta, GA: Centers for Disease Control and Prevention, US Department of Health and Human Services; 2016.

  28. Dunn SP, Birtcher KK, Beavers CJ, Baker WL, Brouse SD, Page RL, et al. The role of the clinical pharmacist in the care of patients with cardiovascular disease. J Am Coll Cardiol. 2015;66:2129–39.

    Article  Google Scholar 

  29. Saseen JJ, Ripley TL, Bondi D, Burke JM, Cohen LJ, McBane S, et al. ACCP clinical pharmacist competencies. Pharmacotherapy. 2017;37:630–6.

    Article  Google Scholar 

  30. American Hypertension Specialist Certification Program (AHSCP). Certified hypertension clinician (CHC); 2020. http://www.ahscp.org/certified-hypertension-clinician/.

  31. Board of Pharmacy Specialties. BPS specialties; 2020. http://bpsweb.org/bps-specialties/.

  32. McBane SE, Dopp AL, Abe A, Benavides S, Chester EA, Dixon DL, et al. Collaborative drug therapy management and comprehensive medication management—2015. Pharmacotherapy. 2015;35:e39–50.

    Article  Google Scholar 

  33. Kliethermes MA. Understanding health care billing basics. Pharm Today. 2017;23:57–68.

    Article  Google Scholar 

  34. Dixon DL, Salgado TM, Caldas LM, Van Tassell BW, Sisson EM. The 2017 American College of Cardiology/American Heart Association hypertension guideline and opportunities for community pharmacists. J Am Pharm Assoc. 2018;58:382–6.

    Article  Google Scholar 

Download references

Funding

This material is based upon work supported by the Centers for Disease Control and Prevention under Grant No. DP006620.

Author information

Authors and Affiliations

  1. Department of Pharmacotherapy & Outcomes Science, Virginia Commonwealth University School of Pharmacy, Richmond, VA, USA

    Tyler D. Wagner, Morgan C. Jones, Teresa M. Salgado & Dave L. Dixon

  2. Center for Pharmacy Practice Innovation, Virginia Commonwealth University School of Pharmacy, Richmond, VA, USA

    Teresa M. Salgado & Dave L. Dixon

Authors
  1. Tyler D. Wagner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Morgan C. Jones
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Teresa M. Salgado
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Dave L. Dixon
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dave L. Dixon.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wagner, T.D., Jones, M.C., Salgado, T.M. et al. Pharmacist’s role in hypertension management: a review of key randomized controlled trials. J Hum Hypertens 34, 487–494 (2020). https://doi.org/10.1038/s41371-020-0331-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41371-020-0331-7

Search

Advanced search

Quick links